Biomarin Pharmaceutical Inc: Ownership
| Ownership Information |
| Shares Outstanding |
101.00 Mil | | Institutional Ownership (%) | 106.13 | | Top 10 Institutions (%) | 45.20 | | Mutual Fund Ownership (%) | 3.44 | | 5%/Insider Ownership (%) | .66 | | Float (%) | 99.34 |
| Ownership Activity |
| Description | # of Holders | Shares |
| Total Positions |
218 | 107,190,304 | | New Positions | 33 | 0 | | Soldout Positions | 144 | 0 | | Net Position Change | -105 | -25,695,688 | | Buyers | 110 | 13,611,259 | | Sellers | 215 | -39,306,948 |
| advertisement |
|
|
|---|
| Institution Name |
Shs Held |
Shs Chg |
%Chg |
$Chg* |
%Out |
%Port |
Rpt Date |
| T. Rowe Price Associates, Inc. |
8,152,590 |
-3,900 |
0.0 |
20,076,018 |
8.1 |
0.1 |
09-30-09 |
| Sectoral Asset Management Inc. |
5,800,746 |
-26,438 |
-0.5 |
13,915,146 |
5.8 |
3.5 |
09-30-09 |
| HealthCor Management, L.P. |
4,900,000 |
1,500,000 |
44.1 |
35,518,000 |
4.9 |
2.6 |
09-30-09 |
| Columbia Wanger Asset Management, L.P. |
4,745,576 |
361,890 |
8.3 |
17,370,676 |
4.7 |
0.5 |
09-30-09 |
| Munder Capital Management |
4,448,294 |
318,339 |
7.7 |
15,956,558 |
4.4 |
1.1 |
09-30-09 |
| Vanguard Group, Inc. |
3,876,304 |
113,338 |
3.0 |
11,343,677 |
3.8 |
0.0 |
09-30-09 |
| Federated Investors, Inc. |
3,845,273 |
10,700 |
0.3 |
9,664,851 |
3.8 |
0.4 |
09-30-09 |
| BlackRock Institutional Trust Company, N.A. |
3,795,292 |
-209,286 |
-5.2 |
6,107,416 |
3.8 |
0.0 |
09-30-09 |
| OrbiMed Advisors, LLC |
3,108,800 |
-495,100 |
-13.7 |
-49,775 |
3.1 |
2.4 |
09-30-09 |
| Cramer Rosenthal McGlynn, LLC |
2,977,469 |
110,900 |
3.9 |
9,085,498 |
3.0 |
0.5 |
09-30-09 |
| Fidelity Management & Research |
2,950,104 |
-1,907,617 |
-39.3 |
-22,491,144 |
2.9 |
0.0 |
09-30-09 |
| Franklin Advisers, Inc. |
2,919,080 |
-388,577 |
-11.7 |
1,144,440 |
2.9 |
0.2 |
09-30-09 |
| Altrinsic Global Advisors, LLC |
2,493,952 |
982,722 |
65.0 |
21,500,352 |
2.5 |
1.6 |
09-30-09 |
| Invesco Aim Management Group, Inc. |
2,243,839 |
95,500 |
4.4 |
7,033,037 |
2.2 |
0.1 |
09-30-09 |
| State Street Global Advisors (US) |
2,045,730 |
-305,940 |
-13.0 |
277,229 |
2.0 |
0.0 |
09-30-09 |
- *Category Headings:
- Shs Held - shares held at report date
- Shs Chg - position change within reporting period
- %Chg - % change
- $Chg - market value of the position change
- %Out - % of shares outstanding
- %Port - % Portfolio
- Rpt Date - report date
Page generated 2/10/2010 9:02 AM Eastern Time